NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.
|Vol / Avg.1.203M / 741.308K||Mkt Cap10.796M|
|Day Range0.651 - 0.800||52 Wk Range0.400 - 2.910|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-07-17||Alliance Global Partners||James Molloy||Initiates Coverage On||Buy||Announces||-||7.50|
|2022-01-07||Maxim Group||Naz Rahman||Initiates Coverage On||Buy||Announces||-||7.00|
You can purchase shares of NeuroSense Therapeutics (NASDAQ: NRSN) through any online brokerage.
There are no as such competitors for NeuroSense Therapeutics.
The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Alliance Global Partners on Monday, July 17, 2023. The analyst firm set a price target for 7.50 expecting NRSN to rise to within 12 months (a possible 849.37% upside). 1 analyst firms have reported ratings in the last year.
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $0.79 last updated Today at December 8, 2023 at 12:52 AM UTC.
There is no dividend information for NeuroSense Therapeutics.
NeuroSense Therapeutics’s Q3 earnings are confirmed for Tuesday, November 28, 2023.
There is no upcoming split for NeuroSense Therapeutics.
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.